Related Experiment Videos
Life-threatening retroperitoneal sepsis after hemorrhoid injection sclerotherapy: report of a case
J Barwell1, R M Watkins, E Lloyd-Davies
1Department of Surgery, Derriford Hospital, Plymouth, United Kingdom.
Diseases of the Colon and Rectum
|May 1, 1999
Abstract:
We present a case of life-threatening retroperitoneal sepsis after injection sclerotherapy for first-degree hemorrhoids.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Receptor activity modifying proteins (RAMPs) interact with the VPAC2 receptor and CRF1 receptors and modulate their function.
British journal of pharmacology·2012
Diagnosis and Management of HIV-Associated Colitis.
Diseases of the colon and rectum·2026
Trends and Survival Outcomes of Adjuvant Chemotherapy in Low-Risk Stage II Colon Cancer: A National Cancer Database Analysis.
Diseases of the colon and rectum·2026
Neighborhood Food Environment and Early-Onset Colorectal Cancer Survival.
Diseases of the colon and rectum·2026
Ruling Out Early Distant Recurrence in Stage III Colon Cancer: A Simple 4-Variable Machine Learning Model with External Validation.
Diseases of the colon and rectum·2026
Hybrid approach with thoracic endovascular treatment and abdominal aortic replacement for acute type B aortic dissection complicated by ruptured abdominal aortic aneurysm.
Journal of vascular surgery cases and innovative techniques·2026
Apixaban-Associated Sublingual Hematoma Causing Pseudo-Ludwig's Angina.
Acute medicine & surgery·2026
Surgical cancellation and changes in postoperative level of care among high and moderate risk surgical patients in the UK.
Journal of the Intensive Care Society·2026
Reading discordant bedside indices in sepsis-induced cardiomyopathy: an evidence-mapping framework for diagnosis and trial design.
Frontiers in cardiovascular medicine·2026